| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049458608 |
| P356 | DOI | 10.1046/J.1523-1755.2002.00148.X |
| P698 | PubMed publication ID | 11849411 |
| P5875 | ResearchGate publication ID | 11512753 |
| P2093 | author name string | Uwe Heemann | |
| Erwei Song | |||
| Hequn Zou | |||
| Balazs Antus | |||
| Shanying Liu | |||
| Amanda Proudfoot | |||
| Yousheng Yao | |||
| Lutz Jens | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 676-685 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Early application of Met-RANTES ameliorates chronic allograft nephropathy | |
| P478 | volume | 61 |
| Q48086566 | A natural CCL5/RANTES variant antagonist for CCR1 and CCR3. |
| Q34130186 | Amelioration of rat adjuvant-induced arthritis by Met-RANTES. |
| Q78601734 | Analysis of gene polymorphisms in the regulatory region of MCP-1, RANTES, and CCR5 in liver transplant recipients |
| Q38223778 | Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy |
| Q73072584 | Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection |
| Q36196440 | CCR1 antagonists in clinical development |
| Q36384883 | CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation |
| Q35583497 | Chemokine receptor‐dependent alloresponses |
| Q35538137 | Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression |
| Q36560836 | Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction |
| Q34786928 | Chemokines: directing leukocyte infiltration into allografts |
| Q37950973 | Chemokines: established and novel targets in atherosclerosis |
| Q41226815 | Clinical significance of monitoring serum level of matrix metalloproteinase 9 in patients with acute kidney allograft rejection |
| Q55334450 | Decreased expression of sirtuin 3 protein correlates with early stage chronic renal allograft dysfunction in a rat kidney model. |
| Q63915166 | Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1 |
| Q31028208 | Dose-response met-RANTES treatment of experimental periodontitis: a narrow edge between the disease severity attenuation and infection control |
| Q36690177 | Dramatic early event in chronic allograft nephropathy: increased but not decreased expression of MMP-9 gene |
| Q35538142 | Emerging roles of endothelial cells in transplant rejection |
| Q26864535 | Experimental rat models of chronic allograft nephropathy: a review |
| Q51545643 | Expression and Significance of RANTES and MCP-1 in Renal Tissue With Chronic Renal Allograft Dysfunction. |
| Q49923255 | Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction |
| Q45065937 | Expression of the integrin-linked kinase in a rat kidney model of chronic allograft nephropathy |
| Q37638064 | Fibrogenesis in kidney transplantation: potential targets for prevention and therapy |
| Q35701867 | Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo |
| Q51812874 | Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation. |
| Q35845313 | Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice. |
| Q54310171 | Increased Expression of p-Akt correlates with Chronic Allograft Nephropathy in a Rat Kidney Model. |
| Q37221054 | MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease |
| Q57790213 | Met-RANTES reduces endothelial progenitor cell homing to activated (glomerular) endothelium in vitro and in vivo |
| Q28567754 | Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis |
| Q91223608 | Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats |
| Q37773387 | Pulmonary vascular disease associated with parasitic infection--the role of schistosomiasis |
| Q40215000 | RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection |
| Q38359455 | Renal allograft fibrosis: biology and therapeutic targets |
| Q37441645 | Renal tubular epithelial cells as immunoregulatory cells in renal allograft rejection |
| Q53570210 | Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. |
| Q38148785 | Targeting CCL5 in inflammation |
| Q27022711 | The divergent roles of macrophages in solid organ transplantation |
| Q35031907 | The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury |
| Q44050707 | Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. |
| Q42705890 | Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy |
| Q43646781 | Ureteral complications: analysis of risk factors in 1000 renal transplants. |
Search more.